Digital health is showing signs of life despite financial markets that seem determined to bring some of 2023’s volatility into the new year. Stocks are up and down, and bond yields are climbing. Inflation is proving stubborn,...more
1/25/2024
/ Capital Markets ,
Digital Health ,
Health Information Technologies ,
Healthcare ,
Initial Public Offering (IPO) ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Venture Capital
For digital health startups, the first two months of this year were a welcome departure from 2022, when high inflation and other economic challenges caused investors to press on the brakes and proceed with caution....more
Digital health has been a powerhouse investment sector since it emerged more than a decade ago. Year-after-year, startups consistently demonstrate their innovations bring real-world benefits and our healthcare system...more
As the financial markets continue to struggle, digital health companies are conserving resources, slowing hiring and minding their burn rate given the uncertainty around the current economic slowdown and whether the economy...more
7/13/2022
/ Apple ,
Artificial Intelligence ,
Big Tech ,
Digital Health ,
Google ,
Healthcare ,
Innovative Technology ,
Investment Opportunities ,
Life Sciences ,
Microsoft ,
Pharmaceutical Industry ,
Popular ,
Startups
The digital health sector emerged as a juggernaut during the COVID-19 pandemic, with almost $15 billion invested in privately-held digital health companies in 2020 and nearly $30 billion invested last year, according to our...more
2/14/2022
/ Capital Markets ,
Digital Health ,
Emerging Technology Companies ,
Initial Public Offering (IPO) ,
Investment ,
Investment Opportunities ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Startups ,
Telehealth ,
Venture Capital
At the end of Q3, aggregate funding raised by digital health startups in 2021 surpassed $20 billion. Although 2021 continues to be a record-breaking year for digital health startups, investors gently tapped the breaks in Q3....more
11/24/2021
/ Capital Raising ,
Clinical Trials ,
Digital Health ,
Financing ,
Health Information Technologies ,
Healthcare ,
Initial Public Offering (IPO) ,
Investment ,
Life Sciences ,
Medical Devices ,
Mental Health ,
Pharmaceutical Industry ,
Startups ,
Telemedicine
In the technology sector, entrepreneurs are often told to “move fast and break things.” But breaking things is something that won’t work in healthcare, so, as an alternative, innovators may consider “moving fast and keeping...more
Last year the digital health sector smashed all previous records for both fundraising and consumer adoption of novel technologies. So far, 2021 is already on track to outshine last year’s impressive numbers. Digital health...more
In prior years, it was almost a foregone conclusion that promising digital health startups would be acquired by other companies before having the opportunity to debut on the public markets. However, that changed in 2019,...more
2/17/2021
/ Digital Health ,
Financial Markets ,
Initial Public Offering (IPO) ,
Innovative Technology ,
Investment Opportunities ,
Life Sciences ,
Pharmaceutical Industry ,
Special Purpose Acquisition Companies (SPACs) ,
Startups ,
Stock Prices ,
Venture Capital
Digital health companies and investors had a remarkable 2020, as fundraising totals broke records and deal volume significantly outpaced previous years. Moreover, the increase in investment activity has triggered more exit...more
When investors survey the digital health sector today, they see nearly every number trending upward.
There is more deal volume than VCs have seen in past years, with the third quarter of 2020 outpacing anything they’ve...more
Virtual healthcare staked out exciting new ground with the recently announced $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo....more
Venture investors are pleased to see digital health companies continue to transform the healthcare system despite unprecedented challenges brought by the COVID-19 pandemic....more
The spread of COVID-19 has created a defining moment for the digital health sector, as many products and services once considered “nice-to-haves” have transformed into necessities....more
The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year....more
1/24/2020
/ Biosimilars ,
Biotechnology ,
Bristol-Myers Squibb ,
China ,
Digital Health ,
Genetic Materials ,
Genetic Testing ,
Investment ,
Investment Opportunities ,
JPMorgan Chase ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
UK Brexit ,
US Trade Policies ,
Venture Capital
Fenwick’s eighth annual Digital Health Investor Summit took place against the backdrop of strong and increasingly diverse investment markets, a focus on clinical validation of digital health tools, and a healthcare system...more
11/21/2019
/ Digital Health ,
Emerging Technology Companies ,
Initial Public Offering (IPO) ,
Investment ,
Investment Opportunities ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Startups ,
Telehealth ,
Venture Capital
Industry leaders anticipate that the use of artificial intelligence in medical imaging will have a substantial clinical impact, ushering in an opportunity to significantly improve decision support in medical image...more
In our 2018 year-end review of life sciences and tech IPOs, we noted that life sciences offerings totaled 67 raising an average of $133 million while there were 45 technology deals raising an average of more than $380...more
The business of animal health has traditionally been dominated by the animal health divisions of big pharma companies. But with Pfizer’s 2013 spin-off of its animal health business, now known as Zoetis, the sector has been...more
5/17/2019
/ Animal Drugs ,
Animal Health ,
Biotechnology ,
Divestiture ,
Industry Consolidation ,
Investment Opportunities ,
Life Sciences ,
Pets ,
Pharmaceutical Industry ,
Popular ,
Startups
With 58 U.S. biopharma IPOs in 2018, the biotech industry entered the new year with confidence. By all appearances, the longest and largest biotech IPO window in history was not going to close anytime soon. ...more
No matter who is doing the counting, 2018 was an off-the-charts year for venture investment in digital health. Here’s a sampling of the tallies...more
The impact of artificial intelligence, or more specifically machine learning, is being felt in every industry sector, but perhaps nowhere more so than in healthcare, where AI funding hit historic highs in 2018, according to...more
Just over a year ago, we reported about the rise of the mega-round in digital health investments. At that time, we tallied nine investment rounds valued at more than $100 million in the first half of 2017. ...more
Two trends stood out in our analysis of private digital health investments in the first quarter of 2018: bigger deals and more investment in companies targeting the regulated portion of the health care market....more
Fenwick’s Sixth Annual Digital Health Investor Summit started on an upbeat note with Rock Health’s Megan Zweig sharing the venture fund’s mid-year funding report. After the uncertainty brought by the 2016 presidential...more
10/12/2017
/ Artificial Intelligence ,
B2B Organizations ,
Digital Health ,
Emerging Growth Companies ,
Information Technology ,
Initial Public Offering (IPO) ,
Investment ,
Life Sciences ,
Pharmaceutical Industry ,
R&D ,
Startups